Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human SYNGR4 ELISA Kit (AC2572)
Cat.#: ASET-1161
Specifications
Description Human SYNGR4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SYNGR4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.021 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.4-6.4 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1663 Human EMP3 ELISA Kit (AC3074) Quantitative inquiry ASET-1394 Mouse Semaphorin 7a ELISA Kit (AC2805) Quantitative inquiry ASET-1232 Human NENF ELISA Kit (AC2643) Quantitative inquiry ASET-1554 Human Neurofilament Heavy Polypeptide ELISA Kit (AC2965) Quantitative inquiry ASET-1678 Mouse Twist ELISA Kit (AC3089) Quantitative inquiry ASET-1977 Human SynGAP ELISA Kit (AC3388) Quantitative inquiry ASET-1468 Sheep IL-6 ELISA Kit (AC2879) Quantitative inquiry ASET-1367 Porcine Syndecan-1 ELISA Kit (AC2778) Quantitative inquiry ASET-2174 Mouse Dopamine ELISA Kit (AC3585) Quantitative inquiry ASET-1668 Rat SIRP alpha ELISA Kit (AC3079) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket